300676 华大基因
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(80,477)408,768130,8832,476,1323,602,693
投资活动产生之现金流量净额55,907(1,750,741)(580,074)(2,292,050)193,976
筹资活动产生之现金流量净额(297,709)(266,882)(1,194,537)1,037,3071,150,428
汇率变动对现金及现金等价物的影响21,75132,822279,379(139,909)(262,515)
现金及现金等价物净增加/(减少)(300,528)(1,576,033)(1,364,349)1,081,4804,684,581
期初现金及现金等价物余额3,555,1415,131,1746,495,5235,410,064725,484
期末现金及现金等价物余额3,254,6133,555,1415,131,1746,491,5445,410,064